Evaluation of Bleeding Events Requiring Hospitalization in Patients With Atrial Fibrillation Receiving Dabigatran, Warfarin, or Antiplatelet Therapy
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Pharmacy Practice"
DOI: 10.1177/0897190016630408
Abstract: Objective: To determine the incidence and severity of bleeding events requiring hospitalization among patients with atrial fibrillation (AF) receiving anticoagulants (dabigatran or warfarin) or antiplatelet agents (eg, aspirin and clopidogrel). Methods: This was a single-center,… read more here.
Keywords: bleeding events; warfarin group; antiplatelet therapy; group ... See more keywords
Efficacy and safety of NOAC versus warfarin in AF patients with left atrial enlargement
Sign Up to like & getrecommendations! Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0243866
Abstract: Background Little is known about the effects of anticoagulation in patients with atrial fibrillation (AF) and left atrial enlargement (LAE). Methods Data of patients with AF were retrieved from Chang Gung Research Database during 2007–2016.… read more here.
Keywords: warfarin group; group; group warfarin; atrial enlargement ... See more keywords